Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000346501

Medchemexpress LLC Lenvatinib mesylate | 857890-39-2 | 99.7% | 100 MG
SDP

Catalog No. 5000346501
Encompass_Preferred

Lenvatinib mesylate (E7080 mesylate) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, and shows potent antitumor activities.

  • Oral, multi-targeted tyrosine kinase inhibitor
  • Inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET
  • Shows potent antitumor activities
  • 85+ Cited Publications

Catalog No. 50-003-46501 Supplier Medchemexpress LLC Supplier No. HY10981A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Lenvatinib mesylate (E7080 mesylate) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, and shows potent antitumor activities.

  • Oral, multi-targeted tyrosine kinase inhibitor
  • Inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET
  • Shows potent antitumor activities
  • 85+ Cited Publications

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.